新聞/Reuters/Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In ObesityBiophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In ObesityRefinitiv閱讀少於1分鐘ALBPSBiophytis SA ALBPS:BIOPHYTIS SA: OBTAINS EMA AUTHORIZATION TO LAUNCH ITS PHASE 2 CLINICAL TRIAL IN OBESITY - SEC FILING閱讀全文無限制訪問Reuters以及TradingView所有其他新聞來源的文章。繼續閱讀